3140 results for «238»
3140 results
Minimally invasive mitral valve surgery - Staying ahead of the game
25 Nov 2024 – From PCR London Valves 2024
Ready to stay ahead in minimally invasive mitral valve surgery? Don't miss this video!
You’ll explore advanced surgical treatment options for valve diseases, learn how the pathophysiology of mitral and tricuspid regurgitation impacts surgical repair techniques, weigh the pros and cons of interventional and surgical approaches for...
TAV-in-TAV for transcatheter heart valve failure
26 Nov 2024 – From PCR London Valves 2024
Struggling with transcatheter heart valve failure? Don’t miss this video!
Learn the essential steps for planning a re-do TAVI procedure, from analysing CT scans to using the re-do TAVI app for a TAV-in-TAV approach, and watch a real-life case of a 91-year-old patient undergoing a redo procedure...
Patient-driven strategies to improve women's experience of heart valve disease: better partnerships for better outcomes
25 Nov 2024 – From PCR London Valves 2024
Curious about how to improve care for women with heart valve disease?
Join this session to explore patient-centred strategies, gain insights from the latest SMART data and dive into the RHEIA trial. You’ll learn how to integrate shared decision-making and strengthen Heart Team partnerships to deliver better outcomes...
TAV-in-SAV for surgical bioprosthetic valve failure
26 Nov 2024 – From PCR London Valves 2024
Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...
TAVI for aortic regurgitation
25 Nov 2024 – From PCR London Valves 2024
Curious about advancing your knowledge in TAVI for aortic regurgitation? Don’t miss this video!
You'll dive into the diagnostic and treatment strategies to optimize outcomes in patients with aortic regurgitation, explore groundbreaking technologies like the Jenavalve Trilogy THV system and gain insights from the latest clinical evidence and...
How to implement a successful structural intervention programme
26 Nov 2024 – From PCR London Valves 2024
Embark on a journey to learn how to implement a successful structural intervention program. Discover the essential requirements for building transcatheter valve intervention capabilities, including the necessary equipment, personnel, and training programs. Gain insights on establishing aortic, mitral, and tricuspid intervention programs, as well as creating...
Rapid-Fire - Transcatheter tricuspid valve replacement
25 Nov 2024 – From PCR London Valves 2024
Dive into a rapid-fire session showcasing the latest advancements in transcatheter tricuspid valve replacement (TTVR). Explore a case of using the LuX TTVR system to salvage a single leaflet device attachment TriClip, a unique case combining multiple interventional strategies for severe tricuspid regurgitation, and the first...
Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence
26 Nov 2024 – From PCR London Valves 2024
Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!
You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and...
Featured research - Aortic valve (Part 11)
26 Nov 2024 – From PCR London Valves 2024
Explore the latest advancements in aortic valve research during this featured session, showcasing selected abstracts from the upcoming PCR London Valves 2024 conference. Delve into topics ranging from the long-term outcomes of bailout valve-in-valve TAVI, the performance of the Navitor THV in bicuspid aortic valves, novel...
Featured Cases - Pulmonary valve intervention
26 Nov 2024 – From PCR London Valves 2024
Explore this session featuring a selection of compelling clinical cases from PCR London Valves 2024, focusing on innovative percutaneous interventions for complex pulmonary valve pathologies. Discover how clinicians are simplifying the challenge of treating dilated main pulmonary arteries, dealing with premature balloon rupture, and tackling giant...
Featured Cases - TAVI in SAVR (Part 2)
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address challenging scenarios in patients with prior surgical aortic valve replacement (SAVR). Gain insights into managing severe aortic regurgitation in degenerated homografts, stopping torrential aortic regurgitation...
Stroke prevention - featured cases
26 Nov 2024 – From PCR London Valves 2024
Dive into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of various stroke prevention strategies during structural heart interventions. Explore techniques such as snaring-assisted TAVR under cerebral embolic protection, single-side access for cerebral embolic protection devices, and the integration...
Featured cases - TAVI in aortic regurgitation
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address aortic regurgitation. Gain insights into the management of pure native aortic regurgitation in surgically unfit patients, the treatment of aortic regurgitation in patients with left...
Featured cases - Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of transcatheter edge-to-edge repair (TEER) for the treatment of tricuspid regurgitation. Explore innovative techniques such as the use of the Pascal device in a patient with dextrocardia, the combination...
Rapid-Fire - TAVI and co-existent coronary artery disease
26 Nov 2024 – From PCR London Valves 2024
Explore a rapid-fire session featuring a selection of compelling clinical cases from PCR London Valves 2024. Discover how interventional cardiologists navigated complex scenarios, including overcoming late radiotherapy consequences, tackling challenging bicuspid aortic stenosis with left main disease, managing TAVI from elective to emergency, performing CTO intervention...
Advanced imaging in tricuspid TEER - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:
- A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
